Regulation of thyroid hormones in the secretion of insulin and gastric inhibitory polypeptide in male rats

Metabolism: Clinical and Experimental

Volumn 46, Issue 2, 1997, Pages 154-158

  Doong, Ming Luen ^b   Wang, J Wen Chuan ^b   Chung, Shu Ching ^b   Liu, Jer Yuh ^b   Hwang, Chensole ^b   Hwang, Chih Yang ^b   Day, C Hsuan ^b   Liu, Yueh Fen ^b   Young, Tze Kong ^b   Ho, L Low Tone ^b   Wang, Paulus S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; LIOTHYRONINE; PROPYLTHIOURACIL; THYROTROPIN;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE RELEASE; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID FUNCTION; THYROIDECTOMY;

EID: 12644273792     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90294-8     Document Type: Article

References (39)

1. Wajchenberg BL, Cesar FP, Lerne CE, et al: Effects of adrenergic stimulating and blocking agents on glucose-induced insulin responses in human thyrotoxicosis. Metabolism 27:1715-1720, 1978
2. Kabadi UM, Eisenstein AB: Glucose intolerance in hyperthyroid-ism: Role of glucagon. J Clin Endocrinol Metab 50:392-396, 1980
3. Ikeda T, Fujiyama K, Hoshino T, et al: Acute effect of thyroid hormone on insulin secretion in cats. Biochem Pharmacol 40:1769-1771, 1990
4. Doar JWH, Stamp TCB, Wynn V, et al: Effects of oral and intravenous glucose loading in thyrotoxicosis. Diabetes 18:633-639, 1969
5. Lenzen S, Fanten U, Hasselblatt A: Thyroxine treatment and insulin secretion in the rat. Diabetologia 11:49-55, 1975
6. Andersen OO, Friis TH, Ottesen B: Glucose tolerance and insulin secretion in hyperthyroidism. Acta Endocrinol (Copenh) 84:576-587, 1977
7. Perez G, Ungaro B, Covelli A, et al: Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. J Clin Endocrinol Metab 51:972-977, 1980
8. Muller MK, Hellwing J, Schafer A, et al: Effect of GIF on insulin release to intravenous glucose infusion in hyperthyroid rats. Horm Metab Res 18:163-166, 1986
9. Ikeda T, Mokuda O, Tominaga M, et al: Glucose intolerance in thyrotoxic rats: Role of insulin, glucagon, and epinephrine. Am J Physiol 255:E843-E849, 1988
10. Levy LJ, Adesman JJ, Spergel G: Studies on the carbohydrate and lipid metabolism in thyroid disease: Effects of glucagon. J Clin Endocrinol Metab 30:372-379, 1970
11. Orsetti A, Collard F, Jaffiol C: Abnormalities of carbohydrate metabolism in experimental and clinical hyperthyroidism: Studies on plasma insulin and on the A- and B-chains of insulin. Acta Diabetol Lat 11:486-492, 1974
12. Brown JC, Mutt V, Pederson RA: Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol 209:57-64, 1970
13. Brown JC: A gastric inhibitory polypeptide. I. The amino acid composition and the tryptic peptides. Can J Biochem 49:255-261, 1971
14. Cataland S, Crockett SE, Brown JC, et al: Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 39:223-228, 1974
15. Lucey MR, Fairclough PD, Wass JAH, et al: Response of circulating somatostatin, insulin, gastrin and GIP to intraduodenal infusion of nutrients in normal man. Clin Endocrinol (Oxf) 21:209-217, 1984
16. Brown JC: Physiological actions of exogenous GIP, in Gastric Inhibitory Polypeptide. New York, NY, Springer-Verlag, 1982, pp 20-33
17. Ishizuka J, Singh P, Greeley GH Jr, et al: A comparison of the insulinotropic and insulin-inhibitory actions of gut peptides on newborn and adult rat islet cells. Pancreas 3:77-82, 1988
18. Bailey CJ, Wilkes LC, Conlon JM, et al: Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets. J Endocrinol 125:375-379, 1990
19. Ahren B, Pettersson M, Uvnas-Moberg K, et al: Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Res Clin Pract 13:153-161, 1991
20. Lu M, Wheeler MB, Leng XH, et al: The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide 1 (7-37). Endocrinology 132:94-100, 1993
21. Osei K, Falko JM, O'Dorisio TM, et al: Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care 8:436-439, 1985
22. Hays JH, Silverman E, Potter BB, et al: Normal gastric inhibitory polypeptide response to oral glucose in hyperthyroidism. J Endocrinol 140:309-312, 1994
23. Chung SC, Chen TS, Wang JWC, et al: Age-related differences in gastric acid secretion and response of gastric inhibitory polypeptide after oral glucose in male rats. Chin J Physiol 36:219-223, 1993
24. Wang PS, Liu JY, Hwang CY, et al: Age-related differences in the spontaneous and thyrotropin-releasing hormone-stimulated release of prolactin and thyrotropin in ovariectomized rats. Neuroendocrinology 49:592-596, 1989
25. Wang PS, Tsai SC, Hwang GS, et al: Calcitonin inhibits testosterone and luteinizing hormone secretion through a mechanism involving an increase of cAMP production in rats. J Bone Miner Res 9:1583-1590, 1994
26. Sheu WJ, Pu HF, Wang SW, et al: Metabolic clearance rate and secretion rate of gastric inhibitory polypeptide in the rat. Chin J Physiol 30:25-33, 1987
27. Chen TS, Yeh GH, Pu HF, et al: Gastric inhibitory polypeptide and gastric acid secretion in pregnant rats. Placenta 16:85-92, 1995
28. Ho LT, Chang BY, Lin SH, et al: Development and validation of a new radioimmunoassay of insulin using semisynthetic human tracer. Proc Natl Sci Counc Repub China A 7:9-15, 1983
29. Tang TK, Wang SW, Wang PS: Effects of thyroidectomy and thyroxine replacement on the responsiveness of the anterior pituitaries from male rats to thyrotropin-releasing hormone in vitro. Experientia 42:1031-1034, 1986+
30. Steel RG, Torrie JH: Principles and Procedures of Statistics. New York, NY, McGraw-Hill, 1960
31. Ho LT, Pu HF, Sheu WJ, et al: Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats. Chin J Physiol 30:103-111, 1987
32. McIntosh C, Yago V, Kwok YN: Beta-funaltrexamine blockade of opioid-induced inhibition of somatostatin secretion from rat stomach. Eur J Pharmacol 259:331-334, 1994
33. Jia X, Brown JC, Kwok YN, et al: Gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach. Can J Physiol Pharmacol 72:1215-1219, 1994
34. Kieffer TJ, Huang Z, McIntosh CH, et al: Gastric inhibitory polypeptide release from a tumor-derived cell line. Am J Physiol 269:E316-E322, 1995
35. Kieffer TJ, Buchan AM, Barker H, et al: Release of gastric inhibitory polypeptide from cultured canine endocrine cells. Am J Physiol 267:E489-E496, 1994
36. Shen DC, Davidson MB, Kuo SW, et al: Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab 66:565-569, 1988
37. Hadley ME: Thyroid hormones, in Endocrinology (ed 3). London, UK, Prentice-Hall International, 1992, p 347
38. Okajima F, Ui M: Adrenergic modulation of insulin secretion in vivo dependent on thyroid states. Am J Physiol 234:E106-E111, 1978
39. Ganong WF: The thyroid gland, in Review of Medical Physiology (ed 17). London, UK, Prentice-Hall International, 1995, p 298